Interleukins in Coronary Heart Disease
Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.1, No. 5)Publication Date: 2018-09-10
Authors : Alyavi A.L. Alyavi B.A. Abdullaev A.X. Tulyaganova D.K. Uzokov J.K. Radjabova D.I. Shodiev J.D. Nuritdinova S.K. Yunusova L.I.;
Page : 38-42
Keywords : Coronary heart disease; angina pectoris; interleukins.;
Abstract
—This article is about the role of interleukins in the pathogenesis of coronary heart disease. It describes the important role of inflammation in the development of ischemic disease of the heart. The role of individual interleukins in the pathogenesis of coronary artery disease and the most frequent forms of it – angina pectoris. It is shown that TGF-β exhibits its anti-inflammatory properties by inhibiting the synthesis of pro-inflammatory cytokines, such as IL-1α, β, TNF-α. The increase in the level of TGF-β1 as a key profibrotic cytokine leads to the development of fibrosis processes in the walls of the heart and vessels. A decrease in the level of anti-inflammatory cytokines in the blood plasma and an increased content of proinflammatory cytokines and acute phase proteins indicate a higher risk and an unfavorable CVD prognosis.
Other Latest Articles
Last modified: 2018-09-14 23:10:16